Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584–595 (2009). Takahashi, K. & Yamanaka, S. Induction of ...

Pluripotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and therefore into all cells of the ...

Dr. Christopher Navara has 15 years of experience in pluripotent stem cell research including both humans and non-human primates. To date he has derived or isolated over 50 cell lines from rhesus ...

In 1981 Martin Evans, Matthew Kaufman and Gail Martin isolated pluripotent embryonic stem cells from ... circulation or metabolism, influence tissue renewal. Nowadays, mini-organs, or 3D-organoids, ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

Researchers at Keio University have begun using induced pluripotent stem cells (iPS) to treat and maybe even cure severe ...

“Historically, the Thomson Lab has been good at making human induced pluripotent stem cells,” says Ron Stewart, Morgridge investigator in computational biology. “But it turns out that making ...

Our group examines the hereditary causes of growth and development using human pluripotent stem cells. We model rare diseases and develop evidence-based treatments for patients with delayed puberty.

Lipids and membranes Starting from induced pluripotent stem cells (iPSCs) differentiated into human Schwann cells ... PMP22 duplication dysregulates lipid metabolism and disrupts the normal ...

The Thomson Lab continued to pioneer new techniques to advance the field, including methods to generate functional arterial cells derived from human pluripotent stem cells — opening the door for ...

The SKI Stem Cell Research Core stocks, characterizes, and distributes human pluripotent stem cell (hPSC) lines. We perform a variety of hPSC-related applications for the stem cell community at SKI ...

More information: Jue Zhang et al. Small-diameter artery grafts engineered from pluripotent stem cells maintain 100% patency in an allogeneic rhesus macaque model, Cell Reports Medicine (2025 ...